Affinium Pharmaceuticals Ltd — Form D/A
Affinium Pharmaceuticals Ltd of Toronto, A6, a company, filed a Form D amendment with the SEC on 2013-09-10. The offering totals $18.9M, of which $18.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-09-10
- Form: D/A
- Accession: 0001398436-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $18.9M
- Amount sold: $18.9M
- Investors: 8
- Date of first sale: 2011-08-19
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-165188
Issuer
- Name: Affinium Pharmaceuticals Ltd
- CIK: 0001398436
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 200 Front Street West, Toronto, A6, M5V 3K2
- Phone: 416-645-6613
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Hamish JM Cameron | Director | Austin, TX |
| Stuart JM Collinson | Director | Austin, TX |
| Damian JM Lamb | Director | Austin, TX |
| Edward Mascioli | Director | Watertown, MA |
| Robert JM Radie | Director | Austin, TX |
| Edward Mascioli | Executive Officer | Watertown, MA |
| Owen G Roberts | Executive Officer | Toronto, A6 |
| Graham JM Boulnois | Director | Toronto, A6 |
Other filings by this issuer (2)
More